Clinical Research Directory
Browse clinical research sites, groups, and studies.
NOVOCART 3D Treatment Following Microfracture Failure
Sponsor: Aesculap Biologics, LLC
Summary
This study is prospective single arm extension study of protocol AAG-G-H-1220. It is open only to participants of AAG-G-H-1220 randomized to the Microfracture treatment group.
Official title: Safety and Efficacy of NOVOCART 3D in the Treatment of Articular Cartilage Defects Following Failure on Microfracture
Key Details
Gender
All
Age Range
18 Years - 65 Years
Study Type
INTERVENTIONAL
Enrollment
30
Start Date
2018-11-30
Completion Date
2029-01
Last Updated
2025-03-21
Healthy Volunteers
No
Conditions
Interventions
NOVOCART 3D
Matrix associated autologous chondrocyte implant
Locations (5)
Rush University Medical Center
Chicago, Illinois, United States
Ohio State University Wexner Medical Center
Columbus, Ohio, United States
Alpine Orthopaedics
North Logan, Utah, United States
University of Alberta
Edmonton, Alberta, Canada
Dalhousie University
Halifax, Nova Scotia, Canada